Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

NCT01679769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 818

Last updated 2015-11-06

No results posted yet for this study

Summary

The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China.

Conditions

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER
  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Guiqiang Wang, MD · Peking University First Hospital

  • Hong Zhao, MD · Peking University First Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-10-31
Completion
2015-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679769 on ClinicalTrials.gov